Arkolith/Insider Trading/ARNA/Form 4

Knobil Katharine

DirectorARENA PHARMACEUTICALS INC (ARNA) · full profile →Form 4 · filed Mar 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2022Other(J)4K——0
Mar 11, 2022Other(J)3K——4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2022Disposed to issuer(D)5K——0
Mar 11, 2022Disposed to issuer(D)3K——0
Mar 11, 2022Disposed to issuer(D)7K——0

Transaction Codes

J
Other acquisition / disposition
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-005914) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML